-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KMQk0vefR1Mc7mM2AfGIEoKv5I/WVXVbz2lRD84BUgWjTqp3tK6cIwdiGSbfMCC3 CHWR326pti7QPtBeVuS1KQ== 0000928385-01-000448.txt : 20010223 0000928385-01-000448.hdr.sgml : 20010223 ACCESSION NUMBER: 0000928385-01-000448 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-57843 FILM NUMBER: 1544154 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SAMARA NOAH A CENTRAL INDEX KEY: 0001106577 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1110 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 SC 13G/A 1 0001.txt AMENDMENT #1 TO SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)/1/ UNITED THERAPEUTICS CORPORATION (Name of Issuer) COMMON STOCK, $ .01 PAR VALUE (Title of Class of Securities) 91307C102 --------------------------- (CUSIP Number) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - -------------------- /1/ The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ----------------------------------------------------------------------------- CUSIP No. 13G Page 2 of 4 Pages - ----------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Noah A. Samara - ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ----------------------------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ----------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER 2,238,729 ------------------------------------------------ OF SHARES 6 SHARED VOTING POWER BENEFICIALLY None ------------------------------------------------ OWNED BY 7 SOLE DISPOSITIVE POWER EACH 2,238,729 ------------------------------------------------ REPORTING 8 SHARED DISPOSITIVE POWER PERSON WITH None - ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,238,729 - ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] - ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.1% - ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - ----------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! - ----------------------------------------------------------------------------- Item 1(a). Name of Issuer: United Therapeutics Corporation Item 1(b) Address of Issuer's Principal Executive Offices: 1110 Spring Street Silver Spring, MD 20910 Item 2(a) Name of Person Filing: Noah A. Samara Item 2(b) Address of Principal Business Office or, if None, Residence: 2400 N Street, N.W. Washington, DC 20037 Item 2(c) Citizenship: United States of America Item 2(d) Title of Class of Securities: Common Stock, $.01 par value Item 2(e) CUSIP Number: 91307C102 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: Not applicable Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 2,238,729 (b) Percent of Class: 11.1% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 2,238,729 (ii) Shared power to vote or to direct the vote None (iii) Sole power to dispose or to direct the disposition of 2,238,729 (iv) Shared power to dispose or to direct the disposition of None Item 5. Ownership of Five Percent or Less of a Class. Not applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 2001 -------------------------- (Date) /S/ -------------------------- (Signature) Noah A. Samara ------------------------ (Name/Title) -----END PRIVACY-ENHANCED MESSAGE-----